Stuart B. Abelson
President, Chairman & CEO, Ora, Inc.
Anthony P. Adamis, MD
Co-Founder, Director & Chair of Advisory Board, EyeBio
Jasmine Ainetchian
US Sr. Director of Marketing, Implantables, Alcon
James Brandt, MD
Professor, Ophthalmology & Vision Science, Director, Glaucoma Service, Vice-Chair, International Programs & New Technologies, UC Davis
Ernest Cavin, PhD
Director International Sales, Ziemer Ophthalmic Systems AG
Paul Chaney
Former President and CEO, PanOptica, Inc.
George A. Cioffi, MD
Columbia University College of Physicians and Surgeons, New York, NY
Emmett Cunningham, Jr., MD, PhD, MPH
Senior Managing Director, Blackstone Life Sciences
Eugene de Juan, Jr., MD
Jean Kelly Stock Distinguished Professor, University of California, San Francisco; Founder and Managing Partner, ForSight Labs, USA
Ronald L. Fellman, MD
Ophthalmologist, Glaucoma Associates of Texas Board member, Cure Glaucoma Foundation
John G. Flanagan, PhD, DSc, FCOptom
Dean, School of Optometry, and Professor of Optometry and Vision Science, University of California, Berkeley
Jeffrey L. Goldberg, MD, PhD
Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA
Eve Higginbotham, SM, MD, ML
Vice Dean, Penn Medicine Office of Inclusion, Diversity, and Equity, Professor of Ophthalmology, University of Pennsylvania
Wende Hutton
General Partner, Canaan
Eliot Lazar, MS, MD
President of elCON Medical Consulting, Principal of elCON Medical
Paul Lee, MD, JD
Professor and Chair of Ophthalmology and Visual Sciences, University of Michigan Medical School; Director, W.K. Kellogg Eye Center
Richard L. Lindstrom, MD
Founder and Attending Surgeon, Minnesota Eye Consultants, Adjunct Clinical Professor Emeritus, University of Minnesota
William Link, PhD
Managing Director, Versant Ventures and Flying L Partners
Cynthia Mattox, MD
Former Director of the Glaucoma and Cataract Service and Vice Chair of Clinical Services, New England Eye Center, Tufts Medical Center
James Mazzo
Global President, Carl Zeiss Meditec Strategic Business Unit Ophthalmic Devices, Executive Chairman, Neurotech Pharmaceuticals, CEO, Avellino
J. Casey McGlynn
Former Partner, Wilson Sonsini Goodrich & Rosati
Gary D. Novack, PhD
President, PharmaLogic Development, Inc.
David E. I. Pyott
Former Chairman and CEO of Allergan, Inc. Irvine, California
Omar R. Sadruddin, MD
Vice President, Global Medical Affairs, Glaukos
Thomas W. Samuelson, MD
Founding Partner, Minnesota Eye Consultants; Adjunct Associate Professor of Ophthalmology at the University of Minnesota
Inder Paul Singh, MD
President, The Eye Centers of Racine & Kenosha
George Spaeth, MD
Ophthalmologist, Director Emeritus of the Glaucoma Service at Wills Eye Hospital
Ellen Strahlman, MD, MHSc
Chief Medical Officer, Becton, Dickinson and Company
Ramin Valian
Vice President, Interventional Glaucoma, Reimbursement and Pipeline, US, Allergan
Tracy M. Valorie, BS, MBA
Strategic Business Consultant and Owner, TMV Associates LLC
Robert Weinreb, MD
Chair & Distinguished Professor of Ophthalmology, Director, Shiley Eye Institute, Director, Hamilton Glaucoma Center, UC San Diego
Ruth D. Williams, MD
Wheaton Eye Clinic, Wheaton, IL
M. Roy Wilson, MD
President, Wayne State University